natgillin/translations-raw huggingface dataset:
, a human clinical safety and efficacy pilot, guinea pig sensitization (Buehler) study, and a haematology and blood biochemistry data and study report.
, kliničku pilot-studiju o sigurnosti i djelotvornosti za ljude, studiju senzibilizacije na zamorcima (Buehler) te podatke o hematološkim i biokemijskim pretragama krvi i izvješće o studiji.
The Commission consulted the European Food Safety Authority (‘the Authority’) on 20 April 2018, asking it to carry out an additional assessment for egg membrane hydrolysate as a novel food in accordance with Regulation (EU) 2015/2283.
Komisija je 20. travnja 2018. zatražila od Europske agencije za sigurnost hrane („Agencija”) da provede dodatnu ocjenu hidrolizata jajne ovojnice kao nove hrane u skladu s Uredbom (EU) 2015/2283.
On 27 June 2018, the Authority adopted ‘Scientific Opinion on the safety of egg membrane hydrolysate as a novel food pursuant to Regulation (EU) 2015/2283’.
Agencija je 27. lipnja 2018. donijela „Znanstveno mišljenje o sigurnosti hidrolizata jajne ovojnice kao nove hrane u skladu s Uredbom (EU) 2015/2283”.
This opinion is in line with the requirements of Article 11 of Regulation (EU) 2015/2283.
To je mišljenje u skladu sa zahtjevima članka 11. Uredbe (EU) 2015/2283.
That opinion gives sufficient grounds to establish that egg membrane hydrolysate, in the proposed uses and use levels when used as an ingredient in food supplements, complies with Article 12(1) of Regulation (EU) 2015/2283.
U mišljenju se iznosi dovoljno informacija na temelju kojih se može utvrditi da je hidrolizat jajne ovojnice u skladu s člankom 12. stavkom 1. Uredbe (EU) 2015/2283 kada se upotrebljava kao sastojak u dodacima prehrani u predloženim upotrebama i količinama.
In its opinion on egg membrane hydrolysate as a novel food, the Authority considered that the data on the manufacturing process served as a basis to assess the safety of egg membrane hydrolysate.
U svojem mišljenju o hidrolizatu jajne ovojnice kao novoj hrani Agencija smatra da su podaci o proizvodnom postupku upotrijebljeni kao osnova za ocjenu sigurnosti hidrolizata jajne ovojnice.
Therefore, the Authority considers that the conclusions on the safety of egg membrane hydrolysate, could not have been arrived at without the data from the unpublished report of this process.
Stoga smatra da zaključci o sigurnosti hidrolizata jajne ovojnice ne bi mogli biti doneseni bez podataka iz neobjavljenog izvješća o tom postupku.
Following the receipt of the Authority's opinion, the Commission requested the Applicant to further clarify the justification provided with regard to their proprietary claim over the studies and to clarify their claim to an exclusive right of reference to those studies, as referred to in points (a) and (b) of Article 26(2) of Regulation (EU) 2015/2283.
Nakon primitka mišljenja Agencije Komisija je zatražila od podnositelja zahtjeva da dodatno pojasni dano obrazloženje u pogledu njegova zahtjeva za zaštitu vlasnički zaštićenih podataka iz studija i da pojasni zahtjev za isključivo pravo upućivanja na te studije, kako je navedeno u članku 26. stavku 2. točkama (a) i (b) Uredbe (EU) 2015/2283.
The Applicant also declared to hold proprietary and exclusive rights to the studies under national law at the time the application was submitted, and that therefore third parties could not lawfully access or use those studies.
Podnositelj zahtjeva izjavio je i da je u trenutku podnošenja zahtjeva bio nositelj vlasničkih i isključivih prava na studije u skladu s nacionalnim pravom te da stoga treće osobe nisu mogle imati zakonit pristup tim studijama niti se koristiti njima.
Accordingly, as provided for under Article 26(2) of Regulation (EU) 2015/2283, the detailed manufacturing process description contained in the Applicant's file and without which the novel food could not have been assessed by the Authority should not be used by the Authority for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation.
U skladu s tim, kako je predviđeno u članku 26. stavku 2. Uredbe (EU) 2015/2283, Agencija detaljan opis proizvodnog postupka, koji je sadržan u dokumentaciji podnositelja zahtjeva i bez kojeg Agencija ne bi mogla ocijeniti novu hranu, ne bi smjela upotrijebiti u korist budućeg podnositelja zahtjeva tijekom razdoblja od pet godina od datuma stupanja na snagu ove Uredbe.
However, restricting the authorisation of this novel food and of the reference to the detailed manufacturing process description contained in the Applicant's file for the sole use of the Applicant does not prevent other applicants from applying for an authorisation to place on the market the same novel food provided that their application is based on legally obtained information supporting the authorisation under this Regulation.
Međutim, ograničenje upotrebe odobrenja te nove hrane i upućivanja na detaljan opis proizvodnog postupka, koji je sadržan u dokumentaciji podnositelja zahtjeva, isključivo na podnositelja zahtjeva ne sprečava druge podnositelje zahtjeva da podnesu zahtjev za odobrenje stavljanja na tržište iste nove hrane pod uvjetom da se njihov zahtjev temelji na zakonito pribavljenim informacijama koje podupiru odobrenje u skladu s ovom Uredbom.
As the source of the novel food comes from eggs, which is listed in Annex II to Regulation (EU) No 1169/2011 of the European Parliament and of the Council as one of a number of substances or products which cause allergies or intolerances, food supplements containing egg membrane hydrolysate should be appropriately labelled following the requirements of Article 21 of that Regulation.
Budući da se nova hrana dobiva od jaja, koja su u Prilogu II. Uredbi (EU) br. 1169/2011 Europskog parlamenta i Vijeća navedena među tvarima ili proizvodima koji uzrokuju alergije ili netolerancije, dodatke prehrani koji sadržavaju hidrolizat jajne ovojnice trebalo bi na odgovarajući način označiti u skladu sa zahtjevima članka 21. te uredbe.
The use of egg membrane hydrolysate should be authorised without prejudice to that Directive.
Upotrebu hidrolizata jajne ovojnice trebalo bi odobriti ne dovodeći u pitanje tu direktivu.
Egg membrane hydrolysate as specified in the Annex to this Regulation shall be included in the Union list of authorised novel foods established in Implementing Regulation (EU) 2017/2470.
Hidrolizat jajne ovojnice, kako je naveden u Prilogu ovoj Uredbi, uvrštava se na Unijin popis odobrene nove hrane utvrđen u Provedbenoj uredbi (EU) 2017/2470.
Company: Biova, LLC
društvu: Biova, LLC
Address: 5800 Merle Hay Rd, Suite 14 PO Box 394 Johnston 50131, Iowa USA
Adresa: 5800 Merle Hay Rd, Suite 14 PO Box 394 Johnston 50131, Iowa SAD
is authorised to place on the market within the Union the novel food referred to in paragraph 1, unless a subsequent applicant obtains authorisation for the novel food without reference to the data protected pursuant to Article 2 of this Regulation or with the agreement of Biova, LLC.
odobreno stavljati na tržište u Uniji novu hranu iz stavka 1., osim ako budući podnositelj zahtjeva dobije odobrenje za tu novu hranu bez upućivanja na podatke zaštićene u skladu s člankom 2. ove Uredbe ili uz suglasnost društva Biova, LLC.
The entry in the Union list referred to in the first paragraph shall include the conditions of use and labelling requirements laid down in the Annex to this Regulation.
Unos na Unijin popis iz stavka 1. uključuje uvjete upotrebe i zahtjeve za označivanje utvrđene u Prilogu ovoj Uredbi.
The study contained in the application file on the basis of which the novel food referred to in Article 1 has been assessed by the Authority, claimed by the applicant as fulfilling the requirements laid down in Article 26(2) of Regulation (EU) 2015/2283, shall not be used for the benefit of a subsequent applicant for a period of five years from the date of entry into force of this Regulation without the agreement of Biova, LLC.
Studija iz dokumentacije podnositelja zahtjeva na temelju koje je Agencija ocijenila novu hranu iz članka 1., i za koju podnositelj zahtjeva tvrdi da ispunjava zahtjeve utvrđene u članku 26. stavku 2. Uredbe (EU) 2015/2283, ne smije se upotrebljavati u korist budućih podnositelja zahtjeva tijekom razdoblja od pet godina od datuma stupanja na snagu ove Uredbe bez suglasnosti društva Biova, LLC.
Biova, LLC; February 2015 (unpublished).
Biova, LLC; veljača 2015. (neobjavljeno).
Food Allergy Research and Resource Program, University of Nebraska, Lincoln; April 2014 (unpublished).
Food Allergy Research and Resource Program, University of Nebraska, Lincoln; travanj 2014. (neobjavljeno).
Food Allergy Research and Resource Program, University of Nebraska, Lincoln; February 2008b (unpublished).
Food Allergy Research and Resource Program, University of Nebraska, Lincoln; veljača 2008.b (neobjavljeno).
BioReliance Corporation, Rockville (MD) for NIS Labs, Klamath Falls (OR); January 2016 (unpublished).
BioReliance Corporation, Rockville (MD) for NIS Labs, Klamath Falls (OR); siječanj 2016. (neobjavljeno).
ST&T Consultants, San Francisco (CA) for Biova LLC, Johnston (IA); January 2009a (unpublished).
ST&T Consultants, San Francisco (CA) for Biova LLC, Johnston (IA); siječanj 2009.a (neobjavljeno).
ST&T Consultants, San Francisco (CA) for Biova LLC; July 2009c (unpublished).
ST&T Consultants, San Francisco (CA) for Biova LLC; srpanj 2009.c (neobjavljeno).
ST&T Consultants, San Francisco (CA) for Biova LLC, Johnston (IA); February 2009a (unpublished).
ST&T Consultants, San Francisco (CA) for Biova LLC, Johnston (IA); veljača 2009.a (neobjavljeno).
ST&T Consultants, San Francisco (CA); July 2009c (unpublished).
ST&T Consultants, San Francisco (CA); srpanj 2009.c (neobjavljeno).
EFSA Journal 2018; 16(7):5363
EFSA Journal 2018.; 16(7):5363.
‘Egg membrane hydrolysate
„Hidrolizat jajne ovojnice
The designation of the novel food on the labelling of the foodstuffs containing it shall be “egg membrane hydrolysate”.
Pri označivanju hrane koja sadržava novu hranu navodi se „hidrolizat jajne ovojnice”.
Applicant: Biova, LLC., 5800 Merle Hay Rd, Suite 14 PO Box 394 Johnston 50131, Iowa USA
Podnositelj zahtjeva: Biova, LLC., 5800 Merle Hay Rd, Suite 14 PO Box 394 Johnston 50131, Iowa SAD
During the period of data protection the novel food egg membrane hydrolysate is authorised for placing on the market within the Union only by Biova, LLC. unless a subsequent applicant obtains authorisation for the novel food without reference to the proprietary scientific evidence or scientific data protected in accordance with Article 26 of Regulation (EU) 2015/2283 or with the agreement of Biova, LLC.
Tijekom razdoblja zaštite podataka stavljanje na tržište u Uniji nove hrane hidrolizat jajne ovojnice odobreno je isključivo podnositelju zahtjeva Biova, LLC., osim ako budući podnositelj zahtjeva dobije odobrenje za novu hranu bez upućivanja na vlasnički zaštićene znanstvene dokaze ili znanstvene podatke zaštićene u skladu s člankom 26. Uredbe (EU) 2015/2283 ili uz suglasnost društva Biova, LLC.
End date of the data protection: 25 November 2023’.
Datum prestanka zaštite podataka: 25. studenoga 2023.”
Food Supplements as defined in Directive 2002/46/EC intended for the general adult population
Dodaci prehrani u smislu Direktive 2002/46/EZ namijenjeni općoj odrasloj populaciji
The egg membrane hydrolysate is derived from the eggshell membranes of chicken eggs.
Hidrolizat jajne ovojnice dobiva se od ovojnice ljuske kokošjih jaja.
The eggshells undergo hydro-mechanical separation in order to obtain the egg membranes, which are then further processed using a patented solubilisation method.
Ljuske jajeta podvrgnu se hidromehaničkoj separaciji kako bi se dobile jajne ovojnice, koje se zatim dalje prerađuju putem patentirane metode otapanja.
Following the solubilisation process, the solution is filtered, concentrated, spray-dried and packaged.
Nakon postupka otapanja otopina se filtrira, koncentrira, suši raspršivanjem i pakira.
Chemical parameters
Kemijski parametri
Total nitrogen-containing compounds (% w/w): ≥ 88
Ukupno spojevi koji sadržavaju dušik (% m/m): ≥ 88
Combustion according to AOAC 990.03 and AOAC 992.15
Izgaranje prema AOAC 990.03 i AOAC 992.15
Collagen (% w/w): ≥ 15
Kolagen (% m/m): ≥ 15
Elastin (% w/w): ≥ 20
Elastin (% m/m): ≥ 20
Total glycosaminoglycans (% w/w): ≥ 5
Ukupni glikozaminoglikani (% m/m): ≥ 5
USP26 (chondroitin sulphate K0032 method)
USP26 (metoda K0032 s kondroitin sulfatom)
Calcium: ≤ 1 %
Kalcij: ≤ 1 %
Physical parameters
Fizikalni parametri
pH: 6,5 – 7,6
pH: 6,5–7,6
Ash (% w/w): ≤ 8
Pepeo (% m/m): ≤ 8
Moisture (% w/w): ≤ 9
Vlaga (% m/m): ≤ 9
Water activity: ≤ 0,3
Aktivnost vode: ≤ 0,3
Solubility (in water): soluble
Topivost (u vodi): topivo
Bulk density: ≥ 0,6 g/cc
Nasipna gustoća: ≥ 0,6 g/cm3
Arsenic ≤ 0,5 mg/kg
Arsen ≤ 0,5 mg/kg
Aerobic plate count: ≤ 2500 CFU/g
Broj aerobnih kolonija: ≤ 2500 CFU/g
Salmonella: Negative (in 25 g)
Salmonella: Negativan nalaz (u 25 g)
Coliforms: ≤ 10 MPN/g
Koliformi: ≤ 10 MPN/g
Mesophilic spore count: ≤ 25 CFU/g
Broj mezofilnih spora: ≤ 25 CFU/g
Thermophilic spore count: ≤ 10 CFU/10 g
Broj termofilnih spora: ≤ 10 CFU/10 g
Yeast: ≤ 10 CFU/g
Kvasac: ≤ 10 CFU/g
Mould: ≤ 200 CFU/g
Plijesan: ≤ 200 CFU/g
CFU: Colony Forming Units; MPN = Most Probable Number; USP: United States Pharmacopeia.’
CFU: jedinice koje tvore kolonije; MPN = najvjerojatniji broj; USP: Farmakopeja SAD-a.”
Authorised on 25 November 2018.
Odobreno 25. studenoga 2018.
Commission Implementing Regulation (EU) 2018/1648
Provedbena uredba Komisije (EU) 2018/1648
authorising the placing on the market of xylo-oligosaccharides as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470
o odobravanju stavljanja na tržište ksilo-oligosaharida kao nove hrane u skladu s Uredbom (EU) 2015/2283 Europskog parlamenta i Vijeća i o izmjeni Provedbene uredbe Komisije (EU) 2017/2470
Pursuant to Article 12 of Regulation (EU) 2015/2283, the Commission is to decide on the authorisation and on the placing on the Union market of a novel food and on the updating of the Union list.
U skladu s člankom 12. Uredbe (EU) 2015/2283 Komisija odlučuje o odobravanju i stavljanju nove hrane na tržište Unije te ažuriranju popisa Unije.
On 4 May 2016, the company Longlive Europe Food Division Ltd (‘the Applicant’) submitted a request to the competent authority of Hungary to place xylo-oligosaccharides on the Union market as a novel food ingredient within the meaning of point (e) of Article 1(2) of Regulation (EC) No 258/97 of the European Parliament and of the Council.
Društvo Longlive Europe Food Division Ltd. („podnositelj zahtjeva”) podnijelo je 4. svibnja 2016. nadležnom tijelu Mađarske zahtjev za stavljanje na tržište Unije ksilo-oligosaharida kao novog sastojka hrane u smislu članka 1. stavka 2. točke (e) Uredbe (EZ) br. 258/97 Europskog parlamenta i Vijeća.
The application requests for xylo-oligosaccharides to be used in a number of food categories, namely, bakery and dairy products, fruit spreads, chocolate confectionery and soy-drinks for the general population.
U zahtjevu se traži da se odobri upotreba ksilo-oligosaharida u više kategorija hrane, i to u pekarskim i mliječnim proizvodima, voćnim namazima, čokoladnim slasticama i napicima od soje za opću populaciju.
While the request for placing xylo-oligosaccharides on the market as a novel food within the Union was submitted to a Member State in accordance with Article 4 of Regulation (EC) No 258/97, the application also meets the requirements laid down in Regulation (EU) 2015/2283.
Zahtjev za stavljanje na tržište u Uniji ksilo-oligosaharida kao nove hrane podnesen je državi članici u skladu s člankom 4. Uredbe (EZ) br. 258/97 te ispunjava i zahtjeve utvrđene u Uredbi (EU) 2015/2283.
On 18 July 2016, the competent authority of Hungary issued its initial assessment report.
Nadležno tijelo Mađarske izdalo je 18. srpnja 2016. izvješće o početnoj ocjeni.
In that report, it concluded that xylo-oligosaccharides meets the criteria for a novel food ingredient set out in Article 3(1) of Regulation (EC) No 258/97.
U tom je izvješću zaključilo da ksilo-oligosaharidi ispunjavaju kriterije za novi sastojak hrane utvrđene u članku 3. stavku 1. Uredbe (EZ) br. 258/97.
Reasoned objections were raised by other Member States within the 60-day period laid down in the first subparagraph of Article 6(4) of Regulation (EC) No 258/97 with regard to the specifications, stability, anticipated daily intake and toxicological studies.
Ostale države članice uložile su obrazložene prigovore u roku od 60 dana propisanom u članku 6. stavku 4. prvom podstavku Uredbe (EZ) br. 258/97 u pogledu specifikacija, stabilnosti, očekivanog dnevnog unosa i toksikoloških studija.
In view of the objections raised by the other Member States, the Commission consulted the European Food Safety Authority (‘the Authority’) on 6 September 2017, asking it to carry out an additional assessment for xylo-oligosaccharides as a novel food ingredient in accordance with Regulation (EC) No 258/97.
S obzirom na prigovore koje su uložile ostale države članice, Komisija je 6. rujna 2017. zatražila od Europske agencije za sigurnost hrane („Agencija”) da provede dodatnu ocjenu ksilo-oligosaharida kao novog sastojka hrane u skladu s Uredbom (EZ) br. 258/97.
On 27 June 2018, the Authority adopted the ‘Scientific Opinion on the safety of xylo-oligosaccharides as a novel food pursuant to Regulation (EU) 2015/2283’.
Agencija je 27. lipnja 2018. donijela „Znanstveno mišljenje o sigurnosti ksilo-oligosaharida kao nove hrane u skladu s Uredbom (EU) br. 2015/2283”.
That opinion gives sufficient grounds to establish that xylo-oligosaccharides in the proposed uses and use levels when used as an ingredient in bakery and dairy products, fruit spreads, chocolates and soy-drinks, complies with Article 12(1) of Regulation (EU) 2015/2283.
U mišljenju se iznosi dovoljno informacija na temelju kojih se može utvrditi da su ksilo-oligosaharidi u skladu s člankom 12. stavkom 1. Uredbe (EU) 2015/2283 ako se upotrebljavaju kao sastojak pekarskih i mliječnih proizvoda, voćnih namaza, čokolada i napitaka od soje u predloženim upotrebama i količinama.
Regulation (EU) No 1308/2013 of the European Parliament and of the Council lays down requirements for milk and milk products which apply to xylo-oligosaccharides when used as an ingredient in milk products.
Uredbom (EU) br. 1308/2013 Europskog parlamenta i Vijeća utvrđeni su zahtjevi za mlijeko i mliječne proizvode koji se primjenjuju na ksilo-oligosaharide kada se upotrebljavaju kao sastojak u mliječnim proizvodima.
Pursuant to point 2 of Part III of Annex VII to that Regulation, xylo-oligosaccharides cannot be used in milk products to replace, in whole or in part, any milk constituent.
U skladu s dijelom III. točkom 2. Priloga VII. toj uredbi ksilo-oligosaharidi ne mogu se upotrebljavati u mliječnim proizvodima kako bi se u cijelosti ili djelomično nadomjestio bilo koji sastojak mlijeka.
The use of xylo-oligosaccharides as a novel food in milk products should therefore be limited accordingly.
Stoga bi upotrebu ksilo-oligosaharida kao nove hrane u mliječnim proizvodima trebalo na odgovarajući način ograničiti.
Xylo-oligosaccharides as specified in the Annex to this Regulation shall be included in the Union list of authorised novel foods established in Implementing Regulation (EU) 2017/2470.
Ksilo-oligosaharidi, kako su navedeni u Prilogu ovoj Uredbi, uvrštavaju se na Unijin popis odobrene nove hrane utvrđen u Provedbenoj uredbi (EU) 2017/2470.
The authorisation provided for in this Article shall be without prejudice to the provisions of Regulation (EU) No 1308/2013.
Odobrenjem iz ovog članka ne dovode se u pitanje odredbe Uredbe (EU) br. 1308/2013.
EFSA Journal 2018;16(7): 5361
EFSA Journal 2018.;16(7): 5361
‘Xylo-oligosaccharides
„Ksilo-oligosaharidi
Maximum levels (**)
Najveće dopuštene količine (**)
The designation of the novel food on the labelling of the foodstuffs containing it shall be “Xylo-oligosaccharides”’
Pri označivanju hrane koja sadržava novu hranu navodi se ‚Ksilo-oligosaharidi’.”
White bread
Bijeli kruh
Whole meal bread
Integralni kruh
Soy drink
Napitak od soje
When used in milk products xylo-oligosaccharides shall not replace, in whole or in part, any milk constituent
Kada se ksilo-oligosaharidi upotrebljavaju u mliječnim proizvodima, oni ne nadomještaju u cijelosti ni djelomično bilo koji sastojak mlijeka.
Maximum levels calculated on the basis of the specifications of Powder form 1.
Najveće dopuštene količine izračunane na temelju specifikacija za prah 1
The novel food is a mixture of xylo-oligosaccharides (XOS) which are obtained from corncobs (Zea mays subsp. mays) via hydrolysis by a xylanase from Trichoderma reesei followed by a purification process.
Nova hrana je smjesa ksilo-oligosaharida (XOS) dobivenih od kukuruznih klipova (Zea mays subsp. mays) hidrolizom ksilanaze iz Trichoderma reesei i naknadnim postupkom pročišćavanja.
Powder form 1
Prah 1
Powder form 2
Prah 2
Syrup form
Sirup
Moisture (%)
Vlaga (%)
Protein (g/100 g)
Bjelančevine (g/100 g)
Ash (%)
Pepeo (%)
Total carbohydrate content (g/100 g)
Ukupan sadržaj ugljikohidrata (g/100 g)
XOS content (dry basis) (g/100 g)
Sadržaj XOS (suha tvar) (g/100 g)
Other carbohydrates (g/100 g) (a)
Ostali ugljikohidrati (g/100 g) (a)
Monosaccharides total (g/100 g)
Monosaharidi ukupno (g/100 g)
Glucose (g/100 g)
Glukoza (g/100 g)
Arabinose (g/100 g)
Arabinoza (g/100 g)
Xylose (g/100 g)
Ksiloza (g/100 g)
Disaccharides total (g/100 g)
Disaharidi ukupno (g/100 g)
Xylobiose (XOS DP2) (g/100 g)
Ksilobioza (XOS DP2) (g/100 g)
Cellobiose (g/100 g)
Celobioza (g/100 g)
Oligosaccharides total (g/100 g)
Oligosaharidi ukupno (g/100 g)
xylotriose (XOS DP3) (g/100 g)
Ksilotrioza (XOS DP3) (g/100 g)
xylotetraose (XOS DP4) (g/100 g)
Ksilotetraoza (XOS DP4) (g/100 g)
xylopentaose (XOS DP5) (g/100 g)
Ksilopentaoza (XOS DP5) (g/100 g)
xylohexaose (XOS DP6) (g/100 g)
Ksiloheksaoza (XOS DP6) (g/100 g)
Xyloheptaose (XOS DP7) (g/100 g)
Ksiloheptaoza (XOS DP7) (g/100 g)
Maltodextrin (g/100 g) (b)
Maltodekstrin (g/100 g) (b)
Copper (mg/kg)
Bakar (mg/kg)
Lead (mg/kg)
Olovo (mg/kg)
Arsenic (mg/kg)
Arsen (mg/kg)
Salmonella (CFU (c)/25 g)
Salmonella (CFU (c)/25 g)
E, coli (MPN (d)/100 g)
E. coli (MPN (d)/100 g)
Yeast (CFU/g)
Kvasac (CFU/g)
Mould (CFU/g)
Plijesan (CFU/g)
DP : Degree of polymerization
DP : stupanj polimerizacije
Other carbohydrates include monosaccharides (glucose, xylose and arabinose) and cellobiose.
Ostali ugljikohidrati uključuju monosaharide (glukoza, ksiloza i arabinoza) i celobiozu.
Maltodextrin content is calculated according to the amount added in the process.
Sadržaj maltodekstrina izračunava se prema količini dodanoj u postupku.
CFU: Colony Forming Units.
CFU: jedinice koje tvore kolonije
MPN: Most Probable Number.’
MPN: najvjerojatniji broj”
Commission Regulation (EU) 2018/1649
Uredba Komisije (EU) 2018/1649
of 5 November 2018
оd 5. studenoga 2018.
Having regard to Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and certain food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No 1601/91, Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC, and in particular Articles 11(3) and 25(3) thereof,
uzimajući u obzir Uredbu (EZ) br. 1334/2008 Europskog parlamenta i Vijeća od 16. prosinca 2008. o aromama i nekim sastojcima hrane s osobinama aroma za upotrebu u i na hrani, te o izmjeni Uredbe Vijeća (EEZ) br. 1601/91, uredbi (EZ) br. 2232/96 i (EZ) br. 110/2008 te Direktive 2000/13/EZ, a posebno njezin članak 11. stavak 3. i članak 25. stavak 3.,
Having regard to Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings, and in particular Article 7(4) thereof,
uzimajući u obzir Uredbu (EZ) br. 1331/2008 Europskog parlamenta i Vijeća od 16. prosinca 2008. o uspostavi zajedničkog postupka odobravanja prehrambenih aditiva, prehrambenih enzima i prehrambenih aroma, a posebno njezin članak 7. stavak 4.,